CLRO is trading at $11.12 (9.5% up) in after-hours trading, recovering after a sharp decline during the regular session.
- The stock has experienced extreme volatility since announcing a reverse merger with Vivani Medical’s Cortigent unit.
- Traders are currently rotating between momentum buying and profit-taking, with price action decoupled from fresh fundamental news.